OCAM
BIOTU

Owl Creek Asset Management’s Biotech Acquisition Company Unit BIOTU Stock Holding History

Owl Creek Asset Management’s Portfolio BIOTU Stock Details BIOTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,000
Closed -$202K – 461
2021
Q4 		$202K Hold
20,000
– – 0.01% 265
2021
Q3 		$201K Hold
20,000
– – 0.01% 248
2021
Q2 		$202K Hold
20,000
– – 0.01% 248
2021
Q1 		$198K Buy
+20,000
New +$206K 0.01% 226

Other funds holding BIOTU

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Owl Creek Asset Management's BIOTU Position: Q1 2022 in Review

Owl Creek Asset Management sold out of Biotech Acquisition Company Unit (BIOTU) in Q1 2022, closing a stake of 20,000 shares — an estimated $202K sold.

Owl Creek Asset Management first reported a position in BIOTU in Q1 2021 and held it in 4 quarters. The position peaked at $202K in Q4 2021. 10 funds tracked by Wall St. Rank hold BIOTU as of Q1 2022.

  • Owl Creek Asset Management reported no remaining Biotech Acquisition Company Unit position as of Q1 2022 after selling out during the quarter.
  • Owl Creek Asset Management sold 20,000 Biotech Acquisition Company Unit shares in Q1 2022, an estimated $202K.
  • Owl Creek Asset Management first reported a position in Biotech Acquisition Company Unit in Q1 2021 and held it in 4 quarters.
  • Owl Creek Asset Management's Biotech Acquisition Company Unit position peaked at $202K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q1 2022.

Based on Owl Creek Asset Management's 13F filing for Q1 2022, filed 16 May 2022.